Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck

NCT00002951 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00002951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
June 30, 1996
Completion date
July 31, 2006
Enrollment
53 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, head and neck cancer